Filtered By:
Condition: Heart Failure
Procedure: Percutaneous Coronary Intervention

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 490 results found since Jan 2013.

Increased Risk of Adverse Cardiovascular Events by Strict Glycemic Control after Percutaneous Coronary Intervention (HbA1c & lt; 6.5% at 2 Years) in Type 2 Diabetes Mellitus Combined with Acute Coronary Syndrome: a 5-years follow-up study
Conclusions: The findings indicated an increased risk of MACEs by strict glycemic control after PCI (2-year HbA1c < 6.5% after PCI) in type 2 diabetes mellitus combined with ACS who underwent PCI.PMID:34166166 | DOI:10.1080/03007995.2021.1947219
Source: Current Medical Research and Opinion - June 24, 2021 Category: Research Authors: Tiangui Yang Peng Fu Jie Chen Xi Fu Changlu Xu Xiaoxia Liu Tiesheng Niu Source Type: research

One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome  - An Analysis of 20,042 Patients From a Japanese Nationwide Registry
CONCLUSIONS: The results from our ACS hospital survivor PCI database suggest the need to improve care for the acute myocardial infarction population to lessen the burden of 30-day mortality due to ACS, heart failure, and sudden cardiac death, as well as 1-year ischemic stroke and heart failure events.PMID:34162778 | DOI:10.1253/circj.CJ-21-0098
Source: Circulation Journal - June 24, 2021 Category: Cardiology Authors: Mitsuaki Sawano Shun Kohsaka Hideki Ishii Yohei Numasawa Kyohei Yamaji Taku Inohara Tetsuya Amano Yuji Ikari Masato Nakamura Source Type: research

Efficacy and Safety of Xinyue Capsule for Coronary Artery Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Evid Based Complement Alternat Med. 2021 Apr 8;2021:6695868. doi: 10.1155/2021/6695868. eCollection 2021.ABSTRACTTo evaluate the efficacy and safety of Xinyue capsule (XYC) in the treatment of coronary artery disease (CAD) after percutaneous coronary intervention (PCI), databases including MEDLINE, EMBASE (Ovid), PubMed, Google Scholar, Cochrane Central Register of Controlled Trials (CENTRAL), China National Knowledge Infrastructure database (CNKI), Wanfang, and VIP were searched to identify randomized controlled trials (RCTs) on XYC in CAD after PCI published before October 2020. Data extraction, methodological quality as...
Source: Evidence-based Complementary and Alternative Medicine - April 26, 2021 Category: Complementary Medicine Authors: Zhonghui Jiang Hua Qu Ying Zhang Fan Zhang Wenli Xiao Dazhuo Shi Zhuye Gao Keji Chen Source Type: research

Factors that influence whether patients with acute coronary syndromes undergo cardiac catheterisation
CONCLUSIONS: Although a larger proportion of patients who presented to catheterisation-capable hospitals underwent catheterisation, patients with similar characteristics were selected for the procedure, independent of the hospital of presentation. Major outcomes for patients were also similar, suggesting equitable management of patients with ACS across Australia.PMID:33792058 | DOI:10.5694/mja2.50997
Source: Med J Aust - April 1, 2021 Category: General Medicine Authors: Michael Ayad Karice Hyun Mario D'Souza Julie Redfern Janice Gullick Mark Ryan David B Brieger Source Type: research